Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT00944294
Eligibility Criteria:
Inclusion Criteria:
* Able to understand and sign an informed consent form.
Exclusion Criteria:
* Women who are of childbearing potential.
* Very low likelihood of coronary artery disease (by American Heart Association and American College of Cardiology standards).
* Documented history of acute myocardial infarction within 30 days.
* Percutaneous coronary intervention or coronary bypass graft surgery within 3 years, unless typical or atypical anginal symptoms are present.
* Reactive airway disease or other contraindication that preclude a patient from receiving adenosine.
* Previous heart transplant or listed to receive a heart transplant.
* Cardiomyopathy (idiopathic dilated, restrictive, hypertrophic).
* History of hemodynamically significant supraventricular tachycardia or sustained ventricular tachycardia.
* Presence of second- or third-degree AV block (in the absence of permanent pacemaker).
* Left ventricular ejection fraction greater than 35%, known prior to the first imaging procedure.
* Presence of advanced heart failure, New York Heart Association Class IV.
* History of vasospastic/Prinzmetal angina.
* Active (under treatment) cancer (except skin cancers).
* Inability to discontinue antianginal medications, Aggrenox®, dipyridamole, and xanthine-containing drugs and foods (including caffeine) as required prior to each imaging procedure.
* Previous participation in a study of binodenoson.
* Any physical or psychosocial condition that, based on the Investigator's judgment, would prevent the patient from completing the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT00944294
Study Brief:
Protocol Section:
NCT00944294